(Q40586285)

21 September 2017

title

Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure (English)

1 reference

21 September 2017

0 references

1 reference

Anju Nohria

1

1 reference

21 September 2017

Sui W Tsang

2

1 reference

21 September 2017

James C Fang

3

1 reference

21 September 2017

Eldrin F Lewis

4

1 reference

21 September 2017

John A Jarcho

5

1 reference

21 September 2017

Gilbert H Mudge

6

1 reference

21 September 2017

Lynne W Stevenson

7

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 May 2003

1 reference

Journal of the American College of Cardiology

21 September 2017

published in

1 reference

21 September 2017

volume

41

1 reference

21 September 2017

issue

10

1 reference

21 September 2017

page(s)

1797-1804

1 reference

Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900309-7

7 January 2021

Long-term use of a left ventricular assist device for end-stage heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900309-7

7 January 2021

Medical therapy of acute myocardial infarction by application of hemodynamic subsets (second of two parts)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900309-7

7 January 2021

Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900309-7

7 January 2021

Mortality in heart failure: clinical variables of prognostic value

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900309-7

7 January 2021

Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900309-7

7 January 2021

The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900309-7

7 January 2021

Renal function, neurohormonal activation, and survival in patients with chronic heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900309-7

7 January 2021

Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900309-7

7 January 2021

Factors influencing the one-year mortality of dilated cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900309-7

7 January 2021

Assessing risk by hemodynamic profile in patients awaiting cardiac transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900309-7

7 January 2021

Importance of hemodynamic response to therapy in predicting survival with ejection fraction less than or equal to 20% secondary to ischemic or nonischemic dilated cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900309-7

7 January 2021

The Abdominojugular Test: Technique and Hemodynamic Correlates

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900309-7

7 January 2021

Bedside cardiovascular examination in patients with severe chronic heart failure: importance of rest or inducible jugular venous distension.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900309-7

7 January 2021

The abdominojugular reflux sign

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900309-7

7 January 2021

A Noninvasive Method of Predicting Pulmonary-Capillary Wedge Pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900309-7

7 January 2021

Accurate detection of elevated left ventricular filling pressure by a simplified bedside application of the Valsalva maneuver

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900309-7

7 January 2021

Hemodynamic profiles of advanced heart failure: association with clinical characteristics and long-term outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900309-7

7 January 2021

Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900309-7

7 January 2021

Freedom from congestion predicts good survival despite previous class IV symptoms of heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900309-7

7 January 2021

Peak VO(2): a simple yet enduring standard

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900309-7

7 January 2021

Clinical assessment and follow-up of functional capacity in patients with chronic congestive cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900309-7

7 January 2021

Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE): design and rationale

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900309-7

7 January 2021

Effect of carvedilol on survival in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900309-7

7 January 2021

A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900309-7

7 January 2021

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900309-7

7 January 2021

A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST).

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900309-7

7 January 2021

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900309-7

7 January 2021

10.1016/S0735-1097(03)00309-7

Identifiers

DOI

1 reference

21 September 2017

1 reference